Gut commensal Enterocloster species host inoviruses that are secreted in vitro and in vivo.


Journal

Microbiome
ISSN: 2049-2618
Titre abrégé: Microbiome
Pays: England
ID NLM: 101615147

Informations de publication

Date de publication:
30 03 2023
Historique:
received: 09 10 2022
accepted: 17 02 2023
medline: 31 3 2023
entrez: 29 3 2023
pubmed: 30 3 2023
Statut: epublish

Résumé

Bacteriophages in the family Inoviridae, or inoviruses, are under-characterized phages previously implicated in bacterial pathogenesis by contributing to biofilm formation, immune evasion, and toxin secretion. Unlike most bacteriophages, inoviruses do not lyse their host cells to release new progeny virions; rather, they encode a secretion system that actively pumps them out of the bacterial cell. To date, no inovirus associated with the human gut microbiome has been isolated or characterized. In this study, we utilized in silico, in vitro, and in vivo methods to detect inoviruses in bacterial members of the gut microbiota. By screening a representative genome library of gut commensals, we detected inovirus prophages in Enterocloster spp. (formerly Clostridium spp.). We confirmed the secretion of inovirus particles in in vitro cultures of these organisms using imaging and qPCR. To assess how the gut abiotic environment, bacterial physiology, and inovirus secretion may be linked, we deployed a tripartite in vitro assay that progressively evaluated bacterial growth dynamics, biofilm formation, and inovirus secretion in the presence of changing osmotic environments. Counter to other inovirus-producing bacteria, inovirus production was not correlated with biofilm formation in Enterocloster spp. Instead, the Enterocloster strains had heterogeneous responses to changing osmolality levels relevant to gut physiology. Notably, increasing osmolality induced inovirus secretion in a strain-dependent manner. We confirmed inovirus secretion in a gnotobiotic mouse model inoculated with individual Enterocloster strains in vivo in unperturbed conditions. Furthermore, consistent with our in vitro observations, inovirus secretion was regulated by a changed osmotic environment in the gut due to osmotic laxatives. In this study, we report on the detection and characterization of novel inoviruses from gut commensals in the Enterocloster genus. Together, our results demonstrate that human gut-associated bacteria can secrete inoviruses and begin to elucidate the environmental niche filled by inoviruses in commensal bacteria. Video Abstract.

Sections du résumé

BACKGROUND
Bacteriophages in the family Inoviridae, or inoviruses, are under-characterized phages previously implicated in bacterial pathogenesis by contributing to biofilm formation, immune evasion, and toxin secretion. Unlike most bacteriophages, inoviruses do not lyse their host cells to release new progeny virions; rather, they encode a secretion system that actively pumps them out of the bacterial cell. To date, no inovirus associated with the human gut microbiome has been isolated or characterized.
RESULTS
In this study, we utilized in silico, in vitro, and in vivo methods to detect inoviruses in bacterial members of the gut microbiota. By screening a representative genome library of gut commensals, we detected inovirus prophages in Enterocloster spp. (formerly Clostridium spp.). We confirmed the secretion of inovirus particles in in vitro cultures of these organisms using imaging and qPCR. To assess how the gut abiotic environment, bacterial physiology, and inovirus secretion may be linked, we deployed a tripartite in vitro assay that progressively evaluated bacterial growth dynamics, biofilm formation, and inovirus secretion in the presence of changing osmotic environments. Counter to other inovirus-producing bacteria, inovirus production was not correlated with biofilm formation in Enterocloster spp. Instead, the Enterocloster strains had heterogeneous responses to changing osmolality levels relevant to gut physiology. Notably, increasing osmolality induced inovirus secretion in a strain-dependent manner. We confirmed inovirus secretion in a gnotobiotic mouse model inoculated with individual Enterocloster strains in vivo in unperturbed conditions. Furthermore, consistent with our in vitro observations, inovirus secretion was regulated by a changed osmotic environment in the gut due to osmotic laxatives.
CONCLUSION
In this study, we report on the detection and characterization of novel inoviruses from gut commensals in the Enterocloster genus. Together, our results demonstrate that human gut-associated bacteria can secrete inoviruses and begin to elucidate the environmental niche filled by inoviruses in commensal bacteria. Video Abstract.

Identifiants

pubmed: 36991500
doi: 10.1186/s40168-023-01496-z
pii: 10.1186/s40168-023-01496-z
pmc: PMC10061712
doi:

Types de publication

Video-Audio Media Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

65

Informations de copyright

© 2023. The Author(s).

Références

Nat Rev Microbiol. 2021 Aug;19(8):514-527
pubmed: 33785903
J Ind Microbiol Biotechnol. 2007 Jan;34(1):5-8
pubmed: 16491361
Sci Transl Med. 2019 Apr 17;11(488):
pubmed: 30996083
Nature. 2021 Jul;595(7867):415-420
pubmed: 34262212
Cell. 2018 Jun 14;173(7):1742-1754.e17
pubmed: 29906449
Int J Food Microbiol. 2011 Sep 1;149(1):19-27
pubmed: 21620505
J Bacteriol. 2002 Apr;184(7):2030-3
pubmed: 11889111
Infect Immun. 2016 Dec 29;85(1):
pubmed: 27795361
Nat Rev Microbiol. 2009 Oct;7(10):693-702
pubmed: 19756008
Cell Host Microbe. 2015 Nov 11;18(5):549-59
pubmed: 26567508
Food Microbiol. 2012 Aug;31(1):9-16
pubmed: 22475937
Appl Environ Microbiol. 2004 Nov;70(11):6459-65
pubmed: 15528506
J Mol Biol. 2018 Jul 20;430(15):2237-2243
pubmed: 29258817
Langmuir. 2009 Apr 21;25(8):4607-14
pubmed: 19366225
Syst Appl Microbiol. 2003 Mar;26(1):84-9
pubmed: 12747414
Ann N Y Acad Sci. 2000;915:214-22
pubmed: 11193578
Front Cell Infect Microbiol. 2022 Jan 04;11:822562
pubmed: 35059329
Proc Natl Acad Sci U S A. 1986 Aug;83(15):5474-8
pubmed: 2942938
Int J Syst Evol Microbiol. 2020 Jan;70(1):23-34
pubmed: 31782700
Nat Rev Microbiol. 2016 Jan;14(1):20-32
pubmed: 26499895
Diagn Microbiol Infect Dis. 2019 Aug;94(4):337-341
pubmed: 30885396
Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):11941-6
pubmed: 26351661
Nat Med. 2015 Oct;21(10):1228-34
pubmed: 26366711
ISME J. 2009 Mar;3(3):271-82
pubmed: 19005496
EMBO Rep. 2019 Jun;20(6):
pubmed: 30952693
J Bacteriol. 1992 Sep;174(17):5584-92
pubmed: 1512192
Prog Biophys Mol Biol. 2014 Apr;114(2):80-122
pubmed: 24582831
Cell Host Microbe. 2017 Apr 12;21(4):433-442
pubmed: 28407481
J Bacteriol. 1991 Jan;173(2):530-5
pubmed: 1987147
J Biol Chem. 1988 Aug 15;263(23):11575-83
pubmed: 2457024
J Ind Microbiol Biotechnol. 2002 Feb;28(2):118-26
pubmed: 12074052
J Ind Microbiol Biotechnol. 2001 Nov;27(5):287-91
pubmed: 11781803
Proc Natl Acad Sci U S A. 2020 Mar 3;117(9):4724-4731
pubmed: 32071243
Nat Microbiol. 2019 Nov;4(11):1895-1906
pubmed: 31332386
FEMS Microbiol Rev. 2015 Jul;39(4):465-87
pubmed: 25670735
Cell. 2014 Mar 27;157(1):121-41
pubmed: 24679531
Am J Physiol Gastrointest Liver Physiol. 2014 Jun 15;306(12):G1108-16
pubmed: 24789208
Nucleic Acids Res. 1991 May 11;19(9):2498
pubmed: 1840658
Science. 1996 Jun 28;272(5270):1910-4
pubmed: 8658163
Science. 1977 Sep 16;197(4309):1147-60
pubmed: 331474
J Anim Sci Biotechnol. 2020 Feb 20;11:24
pubmed: 32099648
Front Endocrinol (Lausanne). 2019 Nov 29;10:784
pubmed: 31849833
PLoS One. 2013 Dec 13;8(12):e84220
pubmed: 24349568
Science. 2019 Mar 29;363(6434):
pubmed: 30923196
Adv Exp Med Biol. 2008;635:15-28
pubmed: 18841700
Cell Host Microbe. 2020 Nov 11;28(5):724-740.e8
pubmed: 32841606
Curr Issues Mol Biol. 2011;13(2):51-76
pubmed: 21502666
J Mol Biol. 1986 Apr 5;188(3):403-13
pubmed: 3525845
J Virol. 1970 Sep;6(3):333-9
pubmed: 4921123
Gut Pathog. 2013 Aug 13;5(1):23
pubmed: 23941657

Auteurs

Juan C Burckhardt (JC)

Department of Microbiology and Immunology, University of British Columbia, Vancouver, Canada.

Derrick H Y Chong (DHY)

Department of Microbiology and Immunology, University of British Columbia, Vancouver, Canada.

Nicola Pett (N)

Department of Microbiology and Immunology, University of British Columbia, Vancouver, Canada.

Carolina Tropini (C)

Department of Microbiology and Immunology, University of British Columbia, Vancouver, Canada. carolina.tropini@ubc.ca.
School of Biomedical Engineering, University of British Columbia, Vancouver, Canada. carolina.tropini@ubc.ca.
Humans and the Microbiome Program, Canadian Institute for Advanced Research (CIFAR), Toronto, Canada. carolina.tropini@ubc.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH